NCT05382845 Screening for Pregnancy Related Pelvic Girdle Pain
| NCT ID | NCT05382845 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Blekinge County Council Hospital |
| Condition | Pelvic Girdle Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 360 participants |
| Start Date | 2022-05-01 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 360 participants in total. It began in 2022-05-01 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To perform clinical manual pain provocation tests of the pelvic joints in pain free pregnant women early in pregnancy, follow them until delivery, and compare those who develop PPGP with those who don't.
Eligibility Criteria
Inclusion Criteria: * Pregnant women before gestational week 20 without any ongoing symptoms of pain from their pelvic joints. Exclusion Criteria: * Fibromyalgia * sick-leave * working at home * treatment of the pelvic joints during the pregnancy
Contact & Investigator
Stina Lilje, PhD
PRINCIPAL INVESTIGATOR
Karolinska Institutet
Frequently Asked Questions
Who can join the NCT05382845 clinical trial?
This trial is open to female participants only, studying Pelvic Girdle Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05382845 currently recruiting?
Yes, NCT05382845 is actively recruiting participants. Contact the research team at stina.lilje@ki.se; titti.lilje@gmail.com for enrollment information.
Where is the NCT05382845 trial being conducted?
This trial is being conducted at Karlskrona, Sweden.
Who is sponsoring the NCT05382845 clinical trial?
NCT05382845 is sponsored by Blekinge County Council Hospital. The principal investigator is Stina Lilje, PhD at Karolinska Institutet. The trial plans to enroll 360 participants.